Rite Aid Corporation (NYSE:RAD) has been downgraded to Sell in a statement by Zacks Investment Research earlier today.
- Updated: September 29, 2016
Boasting a price of $7.61, Rite Aid Corporation (NYSE:RAD) traded -1.94% lower on the day. With the last stock price close down -1.78% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. Rite Aid Corporation has recorded a 50-day average of $7.79 and a two hundred day average of $7.71. Volume of trade was up over the average, with 23,538,146 shares of RAD changing hands over the typical 16,383,900
Zacks Investment Research has downgraded Rite Aid Corporation (NYSE:RAD) to Sell in a statement released on 09/29/2016.
With a total market value of $0, Rite Aid Corporation has price-earnings ratio of 58.68 with a one year low of $5.92 and a one year high of $8.74 .
A total of 9 equity analysts have released a ratings update on RAD. One equity analyst rating the company a strong buy, five equity analysts rating the company a buy, five equity analysts rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $9.00.
Brief Synopsis About Rite Aid Corporation (NYSE:RAD)
Rite Aid Corporation is a retail drugstore chain. The Company's segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company's Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog. It sells brand and generic prescription drugs, as well as an assortment of front-end products, including health and beauty aids, personal care products, seasonal merchandise, and a private brand product line. Its front-end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday and convenience products. The Company's Pharmacy Services segment consists of EnvisionRx, which provides a range of pharmacy benefit services.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.